Evidence map›Paper›PMID 41552547›Full record

ArticleACS omega2026

Optimizing Electrochemical Deposition for Biodegradable Zinc-Hydroxyapatite Systems in Bone Repair.

Radka Gorejova, Ivana Mojzisova, Evghenii Harea, Tibor Sopcak, Kadir Ozaltin

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Radka GorejovaDepartment of Physical Chemistry, Faculty of Science, Pavol Jozef Šafárik University in Košice, Moyzesova 11, 041 54 Košice, Slovakia.ORCID https://orcid.org/0000-0002-7892-7581
Ivana MojzisovaDepartment of Physical Chemistry, Faculty of Science, Pavol Jozef Šafárik University in Košice, Moyzesova 11, 041 54 Košice, Slovakia.
Evghenii HareaCentre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Třída Tomáše Bati 5678, 76001 Zlín, Czech Republic.ORCID https://orcid.org/0000-0001-5008-1062
Tibor SopcakInstitute of Materials Research, Slovak Academy of Sciences, Watsonova 47, 040 01 Košice, Slovakia.ORCID https://orcid.org/0000-0003-1818-8358
Kadir OzaltinCentre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Třída Tomáše Bati 5678, 76001 Zlín, Czech Republic.ORCID https://orcid.org/0000-0002-7619-5321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biodegradable metals are gradually gaining increased attention as a new option for complementary treatment alongside standard inert metal implants. While magnesium- and iron-based systems have been extensively studied, zinc has recently emerged as a novel candidate due to its moderate degradation rate and essential biological role. However, the use of pure zinc in biomedical applications is limited by its potential cytotoxicity. A widely adopted strategy to overcome these drawbacks involves surface modification with bioactive ceramic coatings, particularly hydroxyapatite (HAp), to promote bone-material integration. In this study, we report a systematic use of electrochemical deposition (ECD) for the fabrication of hydroxyapatite coatings on zinc substrates. This method allows us to precisely tailor the coating morphology and properties under controlled electrochemical conditions, offering a scalable, low-temperature alternative to other deposition techniques. Key deposition parameters including applied current density, deposition time, and the presence of a chelating agent (EDTA-2Na) were optimized to achieve uniform, adherent, and morphologically favorable HAp layers. The optimal conditions (current density of 1.25 mA/cm

Identifiers

PMID41552547
PMCPMC12809557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.